DSpace Repository

Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017

Show simple item record

dc.contributor.author Agudelo-Botero, M.
dc.contributor.author Valdez-Ortiz, R.
dc.contributor.author Giraldo-Rodríguez, L.
dc.contributor.author González-Robledo, M.C.
dc.contributor.author Mino-León, D.
dc.contributor.author Rosales-Herrera, M.F.
dc.contributor.author Cahuana-Hurtado, L.
dc.contributor.author Rojas-Russell, M.E.
dc.contributor.author Dávila-Cervantes, C.A.
dc.date.accessioned 2020-07-14T00:00:52Z
dc.date.available 2020-07-14T00:00:52Z
dc.date.issued 2020
dc.identifier.uri https://hdl.handle.net/20.500.12866/8214
dc.description.abstract Objective To describe the evolution of the burden of chronic kidney disease (CKD) in Mexico by states, sex and subtypes from 1990 to 2017. Design Secondary data analysis based on the Global Burden of Disease Study (GBD) 2017. Participants Mexico and its 32 states. Data were publicly available and de-identified and individuals were not involved. Methods We analysed age-standardised mortality rates, years of life lost (YLL) due to premature death, years lived with disability (YLD) and disability-adjusted life years (DALY), as well as the percentage of change of these indicators between 1990 and 2017. Results From 1990 to 2017, the number of deaths, YLL, YLD and DALY due to CKD increased from 12 395 to 65 033, from 330 717 to 1 544 212, from 86 416 to 210 924 and from 417 133 to 1 755 136, respectively. Age-standardised rates went from 28.7 to 58.1 for deaths (% of change 102.3), from 601.2 to 1296.7 for YLL (% of change 115.7), from 158.3 to 175.4 for YLD (% of change 10.9) and from 759.4 to 1472.2 for DALY (% of change 93.8). The highest burden of CKD was for Puebla and the lowest for Sinaloa. It was also greater for men than women. By subtypes of CKD, diabetes and hypertension were the causes that contributed most to the loss of years of healthy life in the Mexican population. Conclusions Mexico has experienced exponential and unprecedented growth in the burden of CKD with significant differences by states, sex and subtypes. Data from the GBD are key inputs to guide decision-making and focus efforts towards the reduction of inequities in CKD. These results should be considered a valuable resource that can help guide the epidemiological monitoring of this disease and prioritise the most appropriate health interventions. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. en_US
dc.language.iso eng
dc.publisher BMJ Publishing Group
dc.relation.ispartof urn:issn:2044-6055
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Article en_US
dc.subject female en_US
dc.subject human en_US
dc.subject male en_US
dc.subject mortality rate en_US
dc.subject hypertension en_US
dc.subject disease burden en_US
dc.subject diabetes mellitus en_US
dc.subject sex difference en_US
dc.subject cause of death en_US
dc.subject data analysis en_US
dc.subject secondary analysis en_US
dc.subject Mexico en_US
dc.subject Aguascalientes (state) en_US
dc.subject Baja California en_US
dc.subject Baja California Sur en_US
dc.subject Campeche (state) en_US
dc.subject Chiapas en_US
dc.subject chronic kidney failure en_US
dc.subject Coahuila en_US
dc.subject disability-adjusted life year en_US
dc.subject Guanajuato (state) en_US
dc.subject Guerrero en_US
dc.subject Hidalgo en_US
dc.subject Jalisco en_US
dc.subject Michoacan en_US
dc.subject Morelos en_US
dc.subject Nayarit en_US
dc.subject Nuevo Leon en_US
dc.subject Quintana Roo en_US
dc.subject San Luis Potosi (state) en_US
dc.subject Sinaloa en_US
dc.subject Sonora en_US
dc.subject Tabasco en_US
dc.subject Tamaulipas en_US
dc.subject Tlaxcala (state) en_US
dc.subject Veracruz (state) en_US
dc.subject Yucatan en_US
dc.subject Zacatecas (state) en_US
dc.title Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017 en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1136/bmjopen-2019-035285
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.00 es_PE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


Browse

My Account

Statistics